Amblyopia

Lancet

Volumn 367, Issue 9519, 2006, Pages 1343-1351

  Holmes, Jonathan M ^a   Clarke, Michael P ^b  

^a Mayo Clinic   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CITICOLINE; LEVODOPA;

AGE DISTRIBUTION; AMBLYOPIA; ANISOMETROPIA; ASTIGMATISM; DRUG HYPERSENSITIVITY; FLUSHING; HUMAN; HYPERACTIVITY; HYPERMETROPIA; MENTAL DISEASE; MONOCULAR VISION; MYOPIA; OPHTHALMOLOGY; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; REFRACTION ERROR; RETINA IMAGE; REVIEW; SCREENING TEST; SEIZURE; SIDE EFFECT; SPECTACLES; STRABISMUS; TACHYCARDIA; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL STIMULATION; XEROSTOMIA;

EID: 33646062248     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68581-4     Document Type: Review

References (101)

1. von Noorden G., and Campos E. Binocular vision and ocular motility. 6th edn. (2002), Mosby, St Louis, MO
2. Hubel D., and Wiesel T. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol 206 (1970) 419-436
3. Goodyear B., Nicolle D., Humphrey G., and Menon R. Bold fMRI response of early visual areas to perceived contrast in human amblyopia. J Neurophysiol 84 (2000) 1907-1913
4. McKee S., Levi D., and Movshon J. The pattern of visual deficits in amblyopia. J Vision 3 (2003) 380-405
5. Williams C., and Papakostopoulos D. Electro-oculographic abnormalities in amblyopia. Br J Ophthalmol 79 (1995) 218-224
6. von Noorden G., and Crawford M. The lateral geniculate nucleus inhuman strabismic amblyopia. Invest Ophthalmol Vis Sci 33 (1992) 2729-2732
7. Davis A., Sloper J., Neveu M., Hogg C., Morgan M., and Holder G. Electrophysiological and psychophysical differences between early- and late-onset strabismic amblyopia. Invest Ophthalmol Vis Sci 44 (2003) 610-617
8. von Nooden G., and Crawford M. The sensitive period. Trans Ophthalmol Soc UK 99 (1979) 442-446
9. Holmes J., Beck R., Repka M., et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 119 (2001) 1345-1353
10. Attebo K., Mitchell P., Cumming R., et al. Prevalence and causes of amblyopia in an adult population. Ophthalmology 105 (1998) 154-159
11. National Eye Institute Office of Biometry and Epidemiology. Report on the National Eye Institute's Visual Acuity Impairment Survey Pilot Study (1984), US Department of Health and Human Services, Washington, DC
12. Holmes J., Leske D., Burke J., and Hodge D. Birth prevalence of visually significant infantile cataract. Ophthalmic Epidemiol 10 (2003) 67-74
13. Rahi J., and Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. The British Congenital Cataract Interest Group. BMJ 318 (1999) 362-365
14. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120 (2002) 268-278
15. Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol 120 (2002) 281-287
16. Wright K., Edelman P., Walonker F., and Yiu S. Reliability of fixation preference testing in diagnosing amblyopia. Arch Ophthalmol 104 (1986) 549-553
17. Wallace D. Tests of fixation preference for amblyopia. Am Orthopt J 55 (2005) 76-81
18. Getz L., Dobson V., Luna B., and Mash C. Interobserver reliability of the Teller Acuity Card procedure in pediatric patients. Invest Ophthalmol Vis Sci 37 (1996) 180-187
19. Kay H. New method of assessing visual acuity with pictures. Br J Ophthalmol 67 (1983) 131-133
20. Hazell C. Evaluation of the Cardiff acuity test in uniocular amblyopia. Br Orthopt J 52 (1995) 8-15
21. Rydberg A., Ericson B., Lennerstrand G., Jacobson L., and Lindstedt E. Assessment of visual acuity in children aged 1 1/2-6 years, with normal and subnormal vision. Strabismus 7 (1999) 1-24
22. Allen H. A new picture series for preschool vision testing. Am J Ophthalmol 44 (1957) 38-41
23. McGraw P., and Winn B. Glasgow acuity cards: a new test for the measurement of letter acuity in children. Ophthalmic Physiol Opt 13 (1993) 400-404
24. Browder J., and Levy W. Vision testing of young and retarded children. Experience with the British STYCAR screening test. Clin Pediatr 13 (1974) 983-1006
25. Hyvarinen L., Nasanen R., and Laurinen P. New visual acuity test for pre-school children. Acta Ophthalmologica 58 (1980) 507-511
26. Ferris III F., Kassoff A., Bresnick G., and Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 94 (1982) 91-96
27. Beck R., Moke P., Turpin A., et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 135 (2003) 194-205
28. Rice M., Leske D., and Holmes J. Comparison of the amblyopia treatment study HOTV and electronic-early treatment of diabetic retinopathy study visual acuity protocols in children aged 5 to 12 years. Am J Ophthalmol 137 (2004) 278-282
29. Atkinson J., and Braddick O. Assessment of visual acuity in infancy and early childhood. Acta Ophthalmol Scand Suppl (1983) 18-26
30. Stewart C. Comparison of Snellen and log-based acuity scores for school-aged children. Br Orthopt J 57 (2000) 32-38
31. Schmidt P., Ciner E., Cyert L., et al. Comparison of preschool vision screening tests as administered by licensed eye care professionals in the vision in preschoolers study. Ophthalmology 111 (2004) 637-650
32. Williams C., Harrad R., Harvey I., Sparrow J., and ALSPAC study team. Screening for amblyopia in preschool children: results of a population-based randomized controlled trial. Ophthalmic Epidemiol 8 (2001) 279-295
33. Vision in Preschoolers Study Group. Preschool vision screening tests administered by nurse screeners compared with lay screeners in the vision in preschoolers study. Invest Ophthalmol Vis Sci 46 (2005) 2639-2648
34. Konig H., Barry J., Leidl R., and Zrenner E. Cost-effectiveness of orthoptic screening in kindergarten: a decision-anlytic model. Strabismus 8 (2000) 79-90
35. Konig H., and Barry J. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany. Pediatrics 113 (2004) e95-e108
36. Williams C., Northsone K., Harrad R., Sparrow J., Harvey I., and ALSPAC study team. Ambylopia treatment outcomes after screening before and at age three years: follow up from randomised trial. BMJ 324 (2002) 1549-1551
37. Hartmann E., Dobson V., Hailine L., et al. Preschool vision screening: summary of a task force report. Pediatrics 106 (2000) 1105-1116
38. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 121 (2003) 603-611
39. Clarke M., Wright C., Hrisos S., Anderson J., Henderson J., and Richardson S. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ 327 (2003) 1251-1256
40. Richardson S., Wright C., Hrisos S., Buck D., and Clarke M. Stereoacuity in unilateral visual impairment detected at preschool screening: outcomes from a randomized controlled trial. Invest Ophthalmol Vis Sci 46 (2005) 150-154
41. American Academy of Pediatric Committee on Practice and Ambulatory Medicine Section of Ophthalmology. Eye examination and vision screening guidelines in infants, children and young adults by pediatricians: policy statement. Pediatrics 111 (2003) 902-907
42. US Preventative Services Task Force. Screening for visual impairment in children younger than age 5 years: recommendation statement. Ann Fam Med 2 (2004) 263-266
43. Snowdon S., and Stewart-Brown S. Preschool vision screening. Health Technol Assess 1 (1997) 1-83
44. Simons K., and Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol 83 (1999) 582-587
45. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 50 (2005) 123-166
46. Chua B., and Mitchell P. Consequences of amblyopia on education, occupation and long term vision loss. Br J Ophthalmol 88 (2004) 1119-1121
47. Membreno J., Brown M., Brown G., Sharma S., and Beauchamp G. A cost-utility analysis of therapy for amblyopia. Ophthalmology 109 (2002) 2265-2271
48. Adams G., and Karas M. Effect of amblyopia on employment prospects. Br J Ophthalmol 83 (1999) 378
49. Tommila V., and Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol 65 (1981) 575-577
50. Rahi J., Logan S., Timms C., Russell-Eggitt I., and Taylor D. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 360 (2002) 597-602
51. Mallah M., Chakravarthy U., and Hart P. Amblyopia: is visual loss permanent?. Br J Ophthalmol 84 (2000) 952-956
52. Rahi J., Logan S., Borja M., Timms C., Russell-Eggitt I., and Taylor D. Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet 360 (2002) 621-622
53. Lam G., Repka M., and Guyton D. Timing of amblyopia therapy relative to strabismus surgery. Ophthalmology 100 (1993) 1751-1756
54. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 110 (2003) 2075-2087
55. American Academy of Ophthalmology. Pediatric eye evaluations, preferred practice pattern (2002), American Academy of Ophthalmology, San Francisco, CA, USA
56. Moseley M., Neufeld M., McCarry B., et al. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt 22 (2002) 296-299
57. Stewart C., Moseley M., Fielder A., Stephens D., and MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 88 (2004) 1552-1556
58. Beck R. The pediatric eye disease investigator group. J AAPOS 2 (1998) 255-256
59. Loudon S., and Simonsz H. The history of the treatment of amblyopia. Strabismus 13 (2005) 93-106
60. Baldone J. Combined atropine-fluoropryl treatment for selected children with suppression amblyopia. J La State Med Soc 116 (1963) 420-422
61. Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 123 (2005) 149-157
62. Cole S., Beck R., Moke P., et al. The amblyopia treatment index. J AAPOS 5 (2001) 250-254
63. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 121 (2003) 1625-1632
64. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 111 (2004) 2076-2085
65. Morrison D., Palmer N., Sinatra R., and Donahue S. Severe amblyopia of the sound eye resulting from atropine therapy combined with optical penalization. J Pediatr Ophthalmol Strabismus 42 (2005) 52-53
66. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol 136 (2003) 630-639
67. Tan J., Thompson J., and Gottlob I. Differences in the management of amblyopia between European countries. Br J Ophthalmol (2003) 291-296
68. Loudon S., Polling J.-R., Simonsz B., and Simonsz H. Objective survey of the prescription of occlusion therapy for amblyopia. Graefes Arch Clin Exp Ophthalmol 242 (2004) 736-740
69. Keech R., Ottar W., and Zhang L. The minimum occulsion trial for the treatment of amblyopia. Ophthalmology 109 (2002) 2261-2264
70. Awan M., Proudlock F., and Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci 46 (2005) 1435-1439
71. Stewart C., Moseley M., Stephens D., and Fielder A. ROTAS Cooperative. Modelling of treatment dose-response in amblyopia. Invest Ophthalmol Vis Sci 46 (2005) 3595. (abstr) http://www.abstractsonline.com/viewer/mkey=%7B74423071%2D0FB2%2D42B6%2DB3C9%2D3787D20BDD73%7D (search "rotas"; accessed Feb 25, 2006)
72. Stewart C., Moseley M., Stephens D., and Fielder A. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 45 (2004) 3048-3054
73. Stewart C., Fielder A., Stephens D., and Moseley M. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci 46 (2005) 3152-3160
74. Loudon S., Polling J., and Simonsz H. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase. Graefes Arch Clin Exp Ophthalmol 241 (2003) 176-180
75. Loudon S., Polling J., and Simonsz H. A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia. Strabismus 10 (2002) 79-82
76. Newsham D. Parental non-concordance with occlusion therapy. Br J Ophthalmol 84 (2000) 957-962
77. Newsham D. A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy. Br J Ophthalmol 86 (2002) 787-791
78. Searle A., Norman P., Harrad R., and Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 16 (2002) 150-155
79. Gregson R. Why are we so bad at treating amblyopia?. Eye 16 (2002) 461-462
80. Loudon S., Verhoef B., Joosse M., et al. Electronic Recording of Patching for Amblyopia Study (ERPAS): preliminary results. Invest Ophthalmol Vis Sci 44 (2003) 4246. (abstr) http://www.abstractsonline.com/viewer/?mkey=%7BB7EE4F95%2D9F5C%2D4CE7%2DBE3E%2D4546DC966490%7D (search "loudon"; accessed Feb 25, 2006)
81. Hrisos S., Clarke M., and Wright C. The emotional impact of amblyopia treatment in preschool children. Ophthamology 111 (2004) 1550-1556
82. Choog Y., Lukman H., Martin S., and Laws D. Childhood amblyopia treatment: psychosocial implications for patients and primary care givers. Eye 18 (2004) 369-375
83. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 123 (2005) 437-447
84. Park K., Hwang J., and Ahn J. Efficacy of amblyopia therapy initiated after 9 years of age. Eye 18 (2004) 571-574
85. Oliver M., Neumann R., Chaimovitch Y., Gotesman N., and Shimshoni M. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 102 (1986) 340-345
86. Mintz-Hittner H., and Fernandez K. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol 118 (2000) 1535-1541
87. Clarke M., Richardson S., Hrisos S., et al. The UK amblyopia treatment trial: visual acuity and stereoacuity values in treated and untreated unilateral straight eyed amblyopia. In: de Faber J.-T. (Ed). 9th meeting of the International Strabismological Association (2003), Swets & Zeitlinger, Sydney, Australia 167-168
88. Lempert P. Optic nerve hypoplasia and small eyes in presumed amblyopia. J AAPOS 4 (2000) 258-266
89. Lempert P. The Axial length/disc area ratio in anisometropic hyperopic amblyopia. Ophthalmology 111 (2004) 304-308
90. Woodruff G., Hiscox F., Thompson J., and Smith L. Factors affecting the outcome of children treated for amblyopia. Eye 8 (1994) 627-631
91. Simons K., Stein L., Sener E., Vitale S., and Guyton D. Full-time atropine, intermittent atropine and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 104 (1997) 2143-2155
92. Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 9 (2005) 129-136
93. Gottlob I., and Strangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Invest Ophthalmol Vis Sci 31 (1990) 776-780
94. Gottlob I., Charlier J., and Reinecke R. Visual acuities and scotomas after one week of levodopa administration in human amblyopia. Invest Ophthalmol Vis Sci 33 (1992) 2722-2728
95. Gottlob I., Wizov S., and Reinecke R. Visual acuities and scotomas after 3 weeks' levodopa adminstration in adult amblyopia. Graefes Arch Clin Exp Ophthalmol 233 (1995) 407-413
96. Leguire L., Komaromy K., Nairus T., et al. Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus 39 (2002) 326-330
97. Campos E., Schiavi C., Benedetti P., Bolzani R., and Porciatti V. Effect of citicoline on visual acuity in amblyopia: preliminary results. Graefes Arch Clin Exp Ophthalmol 233 (1995) 307-312
98. Campos E., Bolzani R., Schiavi C., Baldi A., and Porciatti V. Cytidin-5′-diphosphocholine enhances the effect of part-time occlusion in amblyopia. Doc Ophthalmol 93 (1997) 247-263
99. Campbell F., Hess R., Watson P., and Banks R. Preliminary results of a physiologically based treatment of amblyopia. Br J Ophthalmol 62 (1978) 748-755
100. Eastgate R., Griffiths G., Waddingham P., et al. Modified virtual reality technology for treatment of amblyopia. Eye (2005). published online April 15. DOI:10.1038/sj.eye.6701882.
101. Waddingham P., Butler T., Cobb S., et al. Preliminary results from the use of the novel Interactive Binocular Treatment (I-BiT) System in the treatment of amblyopia. Eye (2005). published online April 25. DOI:10.1038/sj.eye.6701883.